Stocks of Agilon Health - Current price, Where to buy? Chart
Detail | Data |
---|---|
Stocks: | Agilon Health |
ompany Name: | agilon health, inc. |
Ticker: | AGL |
Exchange: | NYSE |
Outstanding stocks: | 411,056,992 |
24-hour Volume: | 4,778,479 |
Industry: | |
Sector: | |
Number of Employees: | |
Country: | |
City: | |
Address: |
P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
---|---|---|---|---|---|
/ | -29.56 | -0.48 USD | -0.18 USD | 1.63 USD | 1,985,405,184.00 USD |
P/E Ratio: | / |
---|---|
Forward P/E: | -29.56 |
EPS: | -0.48 USD |
Forward EPS: | -0.18 |
Book value per share: | 1.63 USD |
Market capitalization: | 1,985,405,184.00 USD |
Agilon Health
Fundamental Indicators
Indicator | Data |
---|---|
Total Revenue: | 4,316,362,752.00 USD |
Net Income: | -195,046,000.00 USD |
Price-to-Book (P/B) Ratio: | 3.27 |
PEG Ratio: | 0.03 |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
Analysts | Recommendation |
---|---|
Issued Recommendation: | According to our data, the recommendation issued for Agilon Health stocks is: hold |
Number of Analysts: | 14 |
Highest Target Price: | 14 USD |
Lowest Target Price: | 5 USD |
Average Target Price: | 8 USD |
Note: The data is approximate. Recommendations and price forecasts for Agilon Health stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
Dividends | Value |
---|---|
Dividend Amount | According to our data, the company Agilon Health is currently not paying dividends. |
Annual Yield %: | - |
Ex-dividend Date: | - |
Average % Yield for 5 Years: | - |
Payout Ratio: | - |
Value of Last Dividend Paid: | - |
Date of Last Dividend: | - |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy Agilon Health Stocks?
If you're interested in investing in Agilon Health stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of Agilon Health stocks through mobile apps with client support. In this table, you can compare brokers offering real Agilon Health stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
---|---|---|---|---|---|---|---|
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller | Go to eToro | ||||
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer | Go to XTB |
xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
Go to XTB | Go to eToro |
More Information about Agilon Health (AGL)
Agilon Health consistently proves itself as a leader in its industry. Total revenues for the last 12 months exceed 4,316,362,752.00 USD, demonstrating its strong market position and ability to generate high revenues. Negative EBITDA of -216,090,000.00 USD may indicate challenges but also opportunities for Agilon Health to invest in future growth. Debt-to-equity ratio of 0.08 suggests that Agilon Health has a healthy financial structure and effectively manages its debts. This is key to stable growth. Gross margin of 1.61% indicates room for Agilon Health to improve cost efficiency and competitiveness. Lower profit margin of -6.08% suggests opportunities for Agilon Health to increase efficiency and reduce costs.
Indicator | Value |
---|---|
Revenue, Debt, and Cash Flow | |
Company Revenue: | 4,316,362,752.00 USD |
EBITDA: | -216,090,000.00 USD - Negative EBITDA may signal financial challenges or growth investments. |
Earnings Per Share: | -0.48 USD |
Book Value Per Share: | 1.63 USD |
Total Cash: | 488,343,008.00 USD |
Total Cash per Share: | 1.19 USD |
Total Debt: | 52,309,000.00 USD |
Debt to Equity Ratio: | 0.08 |
Quick Ratio: | 1.46 |
Current Ratio: | 1.52 |
Free Cash Flow: | -70,935,376.00 USD |
Operating Cash Flow: | -156,199,008.00 USD |
Company Margins | |
Gross Margins: | 1.61 % |
EBITDA Margins: | -5.01 % |
Operating Margins: | -15.56 % |
Profit Margins: | -6.08 % |
Performance | |
Return on Assets: | -8.4 % |
Return on Equity: | -22.9 % |
Earnings Growth (1 year): | / |
Revenue Growth (1 year): | 53.1 % |
Year-over-Year Quarterly Earnings Growth: | / |
Valuation | |
Market Capitalization: | 1,985,405,184.00 USD |
Enterprise Value: | 1,705,050,880.00 USD |
EV/Revenue: | 0.395 |
EV/EBITDA: | -7.89 |
Number of Shares and Short Shares | |
Float Shares: | 303,998,682 shares |
Shares Outstanding: | 409,542,016 shares |
Held Percent Insiders: | 0.01 % |
Held Percent Institutions: | 110.51 % |
Shares Short: | 47,965,870 |
Shares Short Prior Month: | 44,748,950 |
Date Short Interest: | 2024-02-29 |
Shares Percent Shares Out: | 11.71 % |
Short Ratio: | 8.46 |
Beta: | 0.49 |
Short Percent of Float: | 40.50 % |
Předpokládaný počet akcií: | 409,542,016 |
Frequently Asked Questions (FAQ)
According to our data, Agilon Health does not currently pay dividends, even in 2024.
Agilon Health shares are traded on the stock exchange NYSE under the ticker symbol: AGL. You can buy or trade them with a variety of stock brokers offering real stock trading services.
According to our data, there is a hold recommendation issued for Agilon Health shares by a total of 14 analysts. The average target price prediction is 8 USD per share.
The total number of Agilon Health shares on the exchange is 409,542,016.00, which, at the current market capitalization, values the company at 1,985,405,184.00 USD.